[Experimental study of suppression of reactivation of herpes simplex virus type 1 by cyclooxygenase 2 inhibitor with

Yuan Xia1, Zhen-Ping Huang, Fei Ma

  • 1Department of Ophthalmology, Nanfing General Hospital of Nanjing Military Command, PMA, Nanjing 210002, China. linda_xia@21cn.com

Abstract

Insights

A selective cyclooxygenase 2 (COX-2) inhibitor suppresses herpes virus reactivation. Combining this inhibitor with acyclovir did not significantly improve results for herpes virus reactivation, offering a new prevention method for herpetic simplex keratitis (HSK).

Area of Science:

  • Virology
  • Immunology
  • Pharmacology

Context:

  • Herpes Simplex Virus type 1 (HSV-1) reactivation can cause significant ocular morbidity, such as herpetic simplex keratitis (HSK).
  • UV-B radiation is a known trigger for HSV-1 reactivation.
  • Current treatments for HSV-1 reactivation often involve antiviral medications like acyclovir.

Purpose:

  • To investigate the efficacy of a selective cyclooxygenase 2 (COX-2) inhibitor, lornoxicam, in blocking UV-B-induced herpes virus reactivation.
  • To determine if combining lornoxicam with acyclovir enhances the inhibition of herpes virus reactivation compared to monotherapy.

Summary:

  • An experimental study in mice demonstrated that lornoxicam significantly suppressed HSV-1 reactivation in both the cornea and trigeminal ganglia after UV-B exposure.
  • While both lornoxicam and acyclovir monotherapy reduced viral shedding, their combination did not show a statistically significant enhancement in inhibiting reactivation in the cornea.
  • However, the combination therapy showed a significant benefit in suppressing viral reactivation within the trigeminal ganglia compared to lornoxicam alone.

Impact:

  • These findings suggest that selective COX-2 inhibitors represent a potential therapeutic strategy for preventing herpes virus reactivation.
  • The study provides a novel approach for managing and preventing recurrent herpetic simplex keratitis (HSK).
  • Further research may explore optimizing combination therapies for enhanced efficacy in specific anatomical sites.

Related Concept Videos

Herpes01:28

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...